What is the recommended dosing regimen for tacrolimus (0.1% or 0.03% cream) applied to facial skin in adults and children (including those under 2 years)?

Tacrolimus Face Cream Dosing

For facial atopic dermatitis, apply tacrolimus ointment twice daily to affected areas: use 0.03% strength for children aged 2-15 years and either 0.03% or 0.1% strength for adults aged 16 and older. 1

FDA-Approved Dosing by Age

Adults (≥16 years)

• 0.03% or 0.1% tacrolimus ointment applied twice daily to affected facial areas
• Continue until clearance of signs and symptoms
• No specified maximum duration of treatment course 1

Children (2-15 years)

• 0.03% tacrolimus ointment only applied twice daily to affected facial areas 1, 2
• The 0.1% strength is not approved for pediatric use
• Twice-daily application demonstrates significantly greater efficacy than once-daily (76.7% vs 66.7% median improvement in disease severity) 3

Children Under 2 Years

• Not FDA-approved for this age group 4
• However, off-label use may be necessary when conventional therapies fail, as most topical treatments lack approval in infants 4
• Case reports demonstrate safety and efficacy with 0.03% ointment applied once daily to limited surface areas (10 cm²) in infants as young as 1 month 5

Application Instructions

Apply a thin layer to affected areas only:

• Use twice daily (morning and evening) 1
• Continue treatment until skin clears
• Avoid applying immediately after bathing to reduce burning sensation 1
• Do not occlude treated areas

Facial-Specific Considerations

Tacrolimus is particularly well-suited for facial psoriasis and atopic dermatitis because:

• No risk of skin atrophy unlike topical corticosteroids 1
• Effective on thin skin areas where corticosteroid side effects are most problematic
• For facial psoriasis specifically, 65% of patients achieved clearance or near-clearance with 0.1% tacrolimus after 8 weeks 1

Common Pitfalls to Avoid

Burning and stinging are the most common side effects 1:

• Occur most frequently in first 3-4 days of treatment 3
• More pronounced with tacrolimus than pimecrolimus
• Mitigate by avoiding application immediately post-bathing
• Typically resolve with continued use

Strength selection errors:

• Do not use 0.1% strength in children under 16 years
• For severe pediatric disease, twice-daily 0.03% is more effective than once-daily 3

Maintenance Therapy

For flare prevention after initial clearance:

• Apply 2-3 times weekly to previously affected facial areas 6
• This proactive approach reduces flare risk compared to reactive treatment only when lesions appear
• Continue liberal moisturizer use to all areas 4, 6

Safety Monitoring

• No routine laboratory monitoring required for topical use 2
• Systemic absorption is minimal with topical application 7
• The FDA black box warning regarding malignancy risk lacks clinical evidence of causation; actual lymphoma rates are lower than general population predictions 4
• Avoid concurrent phototherapy due to theoretical increased cancer risk in animal studies 1

Contraindications

• Immunocompromised patients 4
• Pregnancy Category C; not recommended for nursing mothers 1
• Patients with Netherton syndrome or severely impaired skin barrier (risk of systemic absorption) 4